Posts

pozomy-federal-contract
, , ,

Success Story: Vysnova’s Joint Venture Pozomy Federal Awarded HHS Contract For Restructuring of HHSAR

Vysnova is excited to announce continued partnership for its joint venture Pozomy Federal, as a mentor to Capitol Advisors on Technology. Pozomy’s first award entered the second year supporting Health and Human Services (HHS) Office of Acquisition in restructuring of the HHSAR, HHSAR supplement, the Acquisition Workforce Policy that supports the contracting enterprise.
, , , ,

Vysnova’s COVID19 Research Retention Success Story

Vysova explains how they were able to get such a high retention rate while participating in a COVID19 study.

The Logistics Behind Retention: Vysnova and University of Maryland

Providing participants with materials that recognize their time and effort, i.e., Thank You Cards, can help research studies engage those participants more effectively. Study engagement is important because it yields higher response rates, better retention, and higher quality data. This high-quality data was sought among one of the largest COVID-19 Studies among Health Systems in the United States.
, , , ,

SABER II Spotlight and Success Story

Vysnova's goal is to understand and combat infectious diseases and vector-borne illnesses including Malaria, Dengue, Chikungunya as well as the burden and distribution of Swine Flu, Bird Flu, SARS-CoV-2, MERS-CoV, and other emerging infectious diseases.
, , ,

Success Story: Survey of Immune Response to Coronavirus Disease 2019 Infections (SIM-COVID)

Vysnova Partners provides program management support for activities to develop and perform a cross-sectional serology protocol designed to assess the burden and distribution of SARS-CoV-2 infections among US Department of Defense (DoD) forces by measuring antibodies against the SARS-CoV-2 virus...
, ,

Success Story: Strengthening Laboratory Capacity in DRC

Between March 15 and April 3, 2021, Dr. Christopher Mores, Sarah Tritsch, and Abbey Porzucek of George Washington University (GWU), Vysnova’s sub awardee, traveled to the Democratic Republic of Congo (DRC) to build relationships with then the Institut National pour la Recherche Biomedicale (INRB), DRC Ministry of Health (MoH), Provincial Division of Health (DPS), and the laboratory team in Ingende.

The University of Maryland School of Medicine and University of Maryland Medical System’s COVID-19 Study

The COVID-19 Community Research Partnership aims to help understand how possible exposure may lead to infections and identify where rates of infection of COVID-19 are growing, by enrolling participants from different health systems within the US.
, , , ,

Success Story:Pyronaridine-Artesunate (Pyramax®) for the Treatment of Artemisinin and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam

What is Plasmodium falciparum? Plasmodium falciparum is a unicellular protozoan parasite of humans and the deadliest species of Plasmodium that causes malaria in humans. The parasite is transmitted through the bite of a female Anopheles…
, ,

SABER II Success Story: SIM COVID

Vysnova supports NAMRU-2 in conducting this research study including the development of the protocol and related SOPs, getting HPRO approval, performing sample collection at sites, storing and transferring samples to different labs, managing data, and completing data analysis.